Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019

SELL
$41.17 - $56.44 $181,600 - $248,956
-4,411 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$52.95 - $71.34 $15,567 - $20,973
-294 Reduced 6.25%
4,411 $249,000
Q2 2018

Jul 19, 2018

BUY
$56.38 - $68.08 $265,267 - $320,316
4,705 New
4,705 $314,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.